nodes	percent_of_prediction	percent_of_DWPC	metapath
Posaconazole—ABCB1—Tamoxifen—pancreatic cancer	0.0751	0.133	CbGbCtD
Posaconazole—ABCB1—Gemcitabine—pancreatic cancer	0.0647	0.115	CbGbCtD
Posaconazole—ABCB1—Erlotinib—pancreatic cancer	0.0639	0.113	CbGbCtD
Posaconazole—ABCB1—Irinotecan—pancreatic cancer	0.0577	0.102	CbGbCtD
Posaconazole—CYP3A4—Tamoxifen—pancreatic cancer	0.045	0.0797	CbGbCtD
Posaconazole—ABCB1—Docetaxel—pancreatic cancer	0.0423	0.0749	CbGbCtD
Posaconazole—ABCB1—Sunitinib—pancreatic cancer	0.0421	0.0745	CbGbCtD
Posaconazole—CYP3A4—Erlotinib—pancreatic cancer	0.0383	0.0678	CbGbCtD
Posaconazole—CYP3A4—Irinotecan—pancreatic cancer	0.0346	0.0612	CbGbCtD
Posaconazole—ABCB1—Doxorubicin—pancreatic cancer	0.0315	0.0558	CbGbCtD
Posaconazole—CYP3A4—Docetaxel—pancreatic cancer	0.0253	0.0449	CbGbCtD
Posaconazole—CYP3A4—Sunitinib—pancreatic cancer	0.0252	0.0447	CbGbCtD
Posaconazole—CYP3A4—Doxorubicin—pancreatic cancer	0.0189	0.0334	CbGbCtD
Posaconazole—Haematuria—Epirubicin—pancreatic cancer	0.000115	0.000264	CcSEcCtD
Posaconazole—Confusional state—Docetaxel—pancreatic cancer	0.000115	0.000264	CcSEcCtD
Posaconazole—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000114	0.000262	CcSEcCtD
Posaconazole—Oedema—Docetaxel—pancreatic cancer	0.000114	0.000262	CcSEcCtD
Posaconazole—Weight increased—Doxorubicin—pancreatic cancer	0.000114	0.000261	CcSEcCtD
Posaconazole—Epistaxis—Epirubicin—pancreatic cancer	0.000114	0.000261	CcSEcCtD
Posaconazole—Pruritus—Gemcitabine—pancreatic cancer	0.000114	0.000261	CcSEcCtD
Posaconazole—Infection—Docetaxel—pancreatic cancer	0.000113	0.00026	CcSEcCtD
Posaconazole—Weight decreased—Doxorubicin—pancreatic cancer	0.000113	0.00026	CcSEcCtD
Posaconazole—Sinusitis—Epirubicin—pancreatic cancer	0.000113	0.00026	CcSEcCtD
Posaconazole—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000113	0.000259	CcSEcCtD
Posaconazole—Diarrhoea—Irinotecan—pancreatic cancer	0.000113	0.000259	CcSEcCtD
Posaconazole—Agranulocytosis—Epirubicin—pancreatic cancer	0.000112	0.000258	CcSEcCtD
Posaconazole—Pneumonia—Doxorubicin—pancreatic cancer	0.000112	0.000258	CcSEcCtD
Posaconazole—Shock—Docetaxel—pancreatic cancer	0.000112	0.000257	CcSEcCtD
Posaconazole—Nervous system disorder—Docetaxel—pancreatic cancer	0.000112	0.000257	CcSEcCtD
Posaconazole—Pruritus—Fluorouracil—pancreatic cancer	0.000112	0.000256	CcSEcCtD
Posaconazole—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000112	0.000256	CcSEcCtD
Posaconazole—Infestation—Doxorubicin—pancreatic cancer	0.000112	0.000256	CcSEcCtD
Posaconazole—Infestation NOS—Doxorubicin—pancreatic cancer	0.000112	0.000256	CcSEcCtD
Posaconazole—Tachycardia—Docetaxel—pancreatic cancer	0.000111	0.000255	CcSEcCtD
Posaconazole—Skin disorder—Docetaxel—pancreatic cancer	0.000111	0.000254	CcSEcCtD
Posaconazole—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000111	0.000254	CcSEcCtD
Posaconazole—Bradycardia—Epirubicin—pancreatic cancer	0.00011	0.000253	CcSEcCtD
Posaconazole—Diarrhoea—Gemcitabine—pancreatic cancer	0.00011	0.000252	CcSEcCtD
Posaconazole—Renal failure—Doxorubicin—pancreatic cancer	0.00011	0.000252	CcSEcCtD
Posaconazole—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000109	0.000251	CcSEcCtD
Posaconazole—Dizziness—Irinotecan—pancreatic cancer	0.000109	0.00025	CcSEcCtD
Posaconazole—Haemoglobin—Epirubicin—pancreatic cancer	0.000109	0.00025	CcSEcCtD
Posaconazole—Stomatitis—Doxorubicin—pancreatic cancer	0.000109	0.00025	CcSEcCtD
Posaconazole—Jaundice—Doxorubicin—pancreatic cancer	0.000109	0.00025	CcSEcCtD
Posaconazole—Anorexia—Docetaxel—pancreatic cancer	0.000109	0.000249	CcSEcCtD
Posaconazole—Rhinitis—Epirubicin—pancreatic cancer	0.000108	0.000249	CcSEcCtD
Posaconazole—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000108	0.000249	CcSEcCtD
Posaconazole—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000108	0.000249	CcSEcCtD
Posaconazole—Haemorrhage—Epirubicin—pancreatic cancer	0.000108	0.000248	CcSEcCtD
Posaconazole—Hepatitis—Epirubicin—pancreatic cancer	0.000108	0.000248	CcSEcCtD
Posaconazole—Diarrhoea—Fluorouracil—pancreatic cancer	0.000108	0.000248	CcSEcCtD
Posaconazole—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000108	0.000247	CcSEcCtD
Posaconazole—Pharyngitis—Epirubicin—pancreatic cancer	0.000107	0.000247	CcSEcCtD
Posaconazole—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000107	0.000245	CcSEcCtD
Posaconazole—Oedema peripheral—Epirubicin—pancreatic cancer	0.000107	0.000245	CcSEcCtD
Posaconazole—Hypotension—Docetaxel—pancreatic cancer	0.000106	0.000245	CcSEcCtD
Posaconazole—Haematuria—Doxorubicin—pancreatic cancer	0.000106	0.000244	CcSEcCtD
Posaconazole—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000106	0.000244	CcSEcCtD
Posaconazole—Urethral disorder—Epirubicin—pancreatic cancer	0.000106	0.000244	CcSEcCtD
Posaconazole—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000105	0.000242	CcSEcCtD
Posaconazole—Epistaxis—Doxorubicin—pancreatic cancer	0.000105	0.000242	CcSEcCtD
Posaconazole—Vomiting—Irinotecan—pancreatic cancer	0.000105	0.000241	CcSEcCtD
Posaconazole—Sinusitis—Doxorubicin—pancreatic cancer	0.000105	0.00024	CcSEcCtD
Posaconazole—Dizziness—Fluorouracil—pancreatic cancer	0.000104	0.00024	CcSEcCtD
Posaconazole—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000104	0.000239	CcSEcCtD
Posaconazole—Rash—Irinotecan—pancreatic cancer	0.000104	0.000239	CcSEcCtD
Posaconazole—Dermatitis—Irinotecan—pancreatic cancer	0.000104	0.000238	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000104	0.000238	CcSEcCtD
Posaconazole—Headache—Irinotecan—pancreatic cancer	0.000103	0.000237	CcSEcCtD
Posaconazole—Insomnia—Docetaxel—pancreatic cancer	0.000103	0.000237	CcSEcCtD
Posaconazole—Paraesthesia—Docetaxel—pancreatic cancer	0.000102	0.000235	CcSEcCtD
Posaconazole—Erythema multiforme—Epirubicin—pancreatic cancer	0.000102	0.000235	CcSEcCtD
Posaconazole—Vomiting—Gemcitabine—pancreatic cancer	0.000102	0.000234	CcSEcCtD
Posaconazole—Bradycardia—Doxorubicin—pancreatic cancer	0.000102	0.000234	CcSEcCtD
Posaconazole—Dyspnoea—Docetaxel—pancreatic cancer	0.000102	0.000233	CcSEcCtD
Posaconazole—Somnolence—Docetaxel—pancreatic cancer	0.000101	0.000233	CcSEcCtD
Posaconazole—Rash—Gemcitabine—pancreatic cancer	0.000101	0.000232	CcSEcCtD
Posaconazole—Dermatitis—Gemcitabine—pancreatic cancer	0.000101	0.000232	CcSEcCtD
Posaconazole—Eye disorder—Epirubicin—pancreatic cancer	0.000101	0.000232	CcSEcCtD
Posaconazole—Tinnitus—Epirubicin—pancreatic cancer	0.000101	0.000232	CcSEcCtD
Posaconazole—Haemoglobin—Doxorubicin—pancreatic cancer	0.000101	0.000231	CcSEcCtD
Posaconazole—Headache—Gemcitabine—pancreatic cancer	0.000101	0.000231	CcSEcCtD
Posaconazole—Flushing—Epirubicin—pancreatic cancer	0.0001	0.000231	CcSEcCtD
Posaconazole—Cardiac disorder—Epirubicin—pancreatic cancer	0.0001	0.000231	CcSEcCtD
Posaconazole—Vomiting—Fluorouracil—pancreatic cancer	0.0001	0.000231	CcSEcCtD
Posaconazole—Rhinitis—Doxorubicin—pancreatic cancer	0.0001	0.00023	CcSEcCtD
Posaconazole—Dyspepsia—Docetaxel—pancreatic cancer	0.0001	0.00023	CcSEcCtD
Posaconazole—Haemorrhage—Doxorubicin—pancreatic cancer	0.0001	0.00023	CcSEcCtD
Posaconazole—Hepatitis—Doxorubicin—pancreatic cancer	0.0001	0.00023	CcSEcCtD
Posaconazole—Hypoaesthesia—Doxorubicin—pancreatic cancer	9.96e-05	0.000229	CcSEcCtD
Posaconazole—Rash—Fluorouracil—pancreatic cancer	9.96e-05	0.000229	CcSEcCtD
Posaconazole—Dermatitis—Fluorouracil—pancreatic cancer	9.95e-05	0.000228	CcSEcCtD
Posaconazole—Pharyngitis—Doxorubicin—pancreatic cancer	9.94e-05	0.000228	CcSEcCtD
Posaconazole—Decreased appetite—Docetaxel—pancreatic cancer	9.91e-05	0.000227	CcSEcCtD
Posaconazole—Headache—Fluorouracil—pancreatic cancer	9.89e-05	0.000227	CcSEcCtD
Posaconazole—Urinary tract disorder—Doxorubicin—pancreatic cancer	9.89e-05	0.000227	CcSEcCtD
Posaconazole—Oedema peripheral—Doxorubicin—pancreatic cancer	9.86e-05	0.000226	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Docetaxel—pancreatic cancer	9.84e-05	0.000226	CcSEcCtD
Posaconazole—Connective tissue disorder—Doxorubicin—pancreatic cancer	9.84e-05	0.000226	CcSEcCtD
Posaconazole—Fatigue—Docetaxel—pancreatic cancer	9.83e-05	0.000226	CcSEcCtD
Posaconazole—Angiopathy—Epirubicin—pancreatic cancer	9.82e-05	0.000225	CcSEcCtD
Posaconazole—Urethral disorder—Doxorubicin—pancreatic cancer	9.81e-05	0.000225	CcSEcCtD
Posaconazole—Nausea—Irinotecan—pancreatic cancer	9.79e-05	0.000225	CcSEcCtD
Posaconazole—Immune system disorder—Epirubicin—pancreatic cancer	9.77e-05	0.000224	CcSEcCtD
Posaconazole—Mediastinal disorder—Epirubicin—pancreatic cancer	9.75e-05	0.000224	CcSEcCtD
Posaconazole—Pain—Docetaxel—pancreatic cancer	9.75e-05	0.000224	CcSEcCtD
Posaconazole—Constipation—Docetaxel—pancreatic cancer	9.75e-05	0.000224	CcSEcCtD
Posaconazole—Chills—Epirubicin—pancreatic cancer	9.71e-05	0.000223	CcSEcCtD
Posaconazole—Arrhythmia—Epirubicin—pancreatic cancer	9.67e-05	0.000222	CcSEcCtD
Posaconazole—Alopecia—Epirubicin—pancreatic cancer	9.56e-05	0.00022	CcSEcCtD
Posaconazole—Nausea—Gemcitabine—pancreatic cancer	9.54e-05	0.000219	CcSEcCtD
Posaconazole—Mental disorder—Epirubicin—pancreatic cancer	9.48e-05	0.000218	CcSEcCtD
Posaconazole—Erythema multiforme—Doxorubicin—pancreatic cancer	9.47e-05	0.000217	CcSEcCtD
Posaconazole—Malnutrition—Epirubicin—pancreatic cancer	9.42e-05	0.000216	CcSEcCtD
Posaconazole—Erythema—Epirubicin—pancreatic cancer	9.42e-05	0.000216	CcSEcCtD
Posaconazole—Feeling abnormal—Docetaxel—pancreatic cancer	9.39e-05	0.000216	CcSEcCtD
Posaconazole—Nausea—Fluorouracil—pancreatic cancer	9.38e-05	0.000215	CcSEcCtD
Posaconazole—Eye disorder—Doxorubicin—pancreatic cancer	9.36e-05	0.000215	CcSEcCtD
Posaconazole—Tinnitus—Doxorubicin—pancreatic cancer	9.33e-05	0.000214	CcSEcCtD
Posaconazole—Gastrointestinal pain—Docetaxel—pancreatic cancer	9.32e-05	0.000214	CcSEcCtD
Posaconazole—Flushing—Doxorubicin—pancreatic cancer	9.29e-05	0.000213	CcSEcCtD
Posaconazole—Cardiac disorder—Doxorubicin—pancreatic cancer	9.29e-05	0.000213	CcSEcCtD
Posaconazole—Flatulence—Epirubicin—pancreatic cancer	9.28e-05	0.000213	CcSEcCtD
Posaconazole—Dysgeusia—Epirubicin—pancreatic cancer	9.22e-05	0.000212	CcSEcCtD
Posaconazole—Back pain—Epirubicin—pancreatic cancer	9.11e-05	0.000209	CcSEcCtD
Posaconazole—Angiopathy—Doxorubicin—pancreatic cancer	9.08e-05	0.000209	CcSEcCtD
Posaconazole—Muscle spasms—Epirubicin—pancreatic cancer	9.06e-05	0.000208	CcSEcCtD
Posaconazole—Immune system disorder—Doxorubicin—pancreatic cancer	9.04e-05	0.000208	CcSEcCtD
Posaconazole—Mediastinal disorder—Doxorubicin—pancreatic cancer	9.02e-05	0.000207	CcSEcCtD
Posaconazole—Body temperature increased—Docetaxel—pancreatic cancer	9.01e-05	0.000207	CcSEcCtD
Posaconazole—Abdominal pain—Docetaxel—pancreatic cancer	9.01e-05	0.000207	CcSEcCtD
Posaconazole—Chills—Doxorubicin—pancreatic cancer	8.98e-05	0.000206	CcSEcCtD
Posaconazole—Arrhythmia—Doxorubicin—pancreatic cancer	8.94e-05	0.000205	CcSEcCtD
Posaconazole—Vision blurred—Epirubicin—pancreatic cancer	8.88e-05	0.000204	CcSEcCtD
Posaconazole—Alopecia—Doxorubicin—pancreatic cancer	8.85e-05	0.000203	CcSEcCtD
Posaconazole—Mental disorder—Doxorubicin—pancreatic cancer	8.77e-05	0.000201	CcSEcCtD
Posaconazole—Ill-defined disorder—Epirubicin—pancreatic cancer	8.74e-05	0.000201	CcSEcCtD
Posaconazole—Malnutrition—Doxorubicin—pancreatic cancer	8.71e-05	0.0002	CcSEcCtD
Posaconazole—Erythema—Doxorubicin—pancreatic cancer	8.71e-05	0.0002	CcSEcCtD
Posaconazole—Anaemia—Epirubicin—pancreatic cancer	8.71e-05	0.0002	CcSEcCtD
Posaconazole—Agitation—Epirubicin—pancreatic cancer	8.66e-05	0.000199	CcSEcCtD
Posaconazole—Flatulence—Doxorubicin—pancreatic cancer	8.59e-05	0.000197	CcSEcCtD
Posaconazole—Dysgeusia—Doxorubicin—pancreatic cancer	8.53e-05	0.000196	CcSEcCtD
Posaconazole—Malaise—Epirubicin—pancreatic cancer	8.49e-05	0.000195	CcSEcCtD
Posaconazole—Vertigo—Epirubicin—pancreatic cancer	8.46e-05	0.000194	CcSEcCtD
Posaconazole—Syncope—Epirubicin—pancreatic cancer	8.45e-05	0.000194	CcSEcCtD
Posaconazole—Leukopenia—Epirubicin—pancreatic cancer	8.43e-05	0.000194	CcSEcCtD
Posaconazole—Back pain—Doxorubicin—pancreatic cancer	8.43e-05	0.000194	CcSEcCtD
Posaconazole—Hypersensitivity—Docetaxel—pancreatic cancer	8.4e-05	0.000193	CcSEcCtD
Posaconazole—Muscle spasms—Doxorubicin—pancreatic cancer	8.38e-05	0.000192	CcSEcCtD
Posaconazole—Loss of consciousness—Epirubicin—pancreatic cancer	8.28e-05	0.00019	CcSEcCtD
Posaconazole—Cough—Epirubicin—pancreatic cancer	8.22e-05	0.000189	CcSEcCtD
Posaconazole—Vision blurred—Doxorubicin—pancreatic cancer	8.21e-05	0.000189	CcSEcCtD
Posaconazole—Asthenia—Docetaxel—pancreatic cancer	8.18e-05	0.000188	CcSEcCtD
Posaconazole—Convulsion—Epirubicin—pancreatic cancer	8.16e-05	0.000187	CcSEcCtD
Posaconazole—Hypertension—Epirubicin—pancreatic cancer	8.13e-05	0.000187	CcSEcCtD
Posaconazole—Ill-defined disorder—Doxorubicin—pancreatic cancer	8.09e-05	0.000186	CcSEcCtD
Posaconazole—Pruritus—Docetaxel—pancreatic cancer	8.06e-05	0.000185	CcSEcCtD
Posaconazole—Anaemia—Doxorubicin—pancreatic cancer	8.05e-05	0.000185	CcSEcCtD
Posaconazole—Chest pain—Epirubicin—pancreatic cancer	8.02e-05	0.000184	CcSEcCtD
Posaconazole—Myalgia—Epirubicin—pancreatic cancer	8.02e-05	0.000184	CcSEcCtD
Posaconazole—Arthralgia—Epirubicin—pancreatic cancer	8.02e-05	0.000184	CcSEcCtD
Posaconazole—Agitation—Doxorubicin—pancreatic cancer	8.01e-05	0.000184	CcSEcCtD
Posaconazole—Anxiety—Epirubicin—pancreatic cancer	7.99e-05	0.000183	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	7.96e-05	0.000183	CcSEcCtD
Posaconazole—Discomfort—Epirubicin—pancreatic cancer	7.92e-05	0.000182	CcSEcCtD
Posaconazole—Malaise—Doxorubicin—pancreatic cancer	7.86e-05	0.00018	CcSEcCtD
Posaconazole—Dry mouth—Epirubicin—pancreatic cancer	7.84e-05	0.00018	CcSEcCtD
Posaconazole—Vertigo—Doxorubicin—pancreatic cancer	7.83e-05	0.00018	CcSEcCtD
Posaconazole—Syncope—Doxorubicin—pancreatic cancer	7.82e-05	0.000179	CcSEcCtD
Posaconazole—Leukopenia—Doxorubicin—pancreatic cancer	7.8e-05	0.000179	CcSEcCtD
Posaconazole—Diarrhoea—Docetaxel—pancreatic cancer	7.8e-05	0.000179	CcSEcCtD
Posaconazole—Confusional state—Epirubicin—pancreatic cancer	7.75e-05	0.000178	CcSEcCtD
Posaconazole—Oedema—Epirubicin—pancreatic cancer	7.69e-05	0.000176	CcSEcCtD
Posaconazole—Loss of consciousness—Doxorubicin—pancreatic cancer	7.66e-05	0.000176	CcSEcCtD
Posaconazole—Infection—Epirubicin—pancreatic cancer	7.64e-05	0.000175	CcSEcCtD
Posaconazole—Cough—Doxorubicin—pancreatic cancer	7.6e-05	0.000175	CcSEcCtD
Posaconazole—Shock—Epirubicin—pancreatic cancer	7.56e-05	0.000174	CcSEcCtD
Posaconazole—Convulsion—Doxorubicin—pancreatic cancer	7.55e-05	0.000173	CcSEcCtD
Posaconazole—Nervous system disorder—Epirubicin—pancreatic cancer	7.54e-05	0.000173	CcSEcCtD
Posaconazole—Dizziness—Docetaxel—pancreatic cancer	7.54e-05	0.000173	CcSEcCtD
Posaconazole—Thrombocytopenia—Epirubicin—pancreatic cancer	7.53e-05	0.000173	CcSEcCtD
Posaconazole—Hypertension—Doxorubicin—pancreatic cancer	7.52e-05	0.000173	CcSEcCtD
Posaconazole—Tachycardia—Epirubicin—pancreatic cancer	7.5e-05	0.000172	CcSEcCtD
Posaconazole—Skin disorder—Epirubicin—pancreatic cancer	7.47e-05	0.000171	CcSEcCtD
Posaconazole—Hyperhidrosis—Epirubicin—pancreatic cancer	7.43e-05	0.000171	CcSEcCtD
Posaconazole—Chest pain—Doxorubicin—pancreatic cancer	7.42e-05	0.00017	CcSEcCtD
Posaconazole—Arthralgia—Doxorubicin—pancreatic cancer	7.42e-05	0.00017	CcSEcCtD
Posaconazole—Myalgia—Doxorubicin—pancreatic cancer	7.42e-05	0.00017	CcSEcCtD
Posaconazole—Anxiety—Doxorubicin—pancreatic cancer	7.39e-05	0.00017	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	7.37e-05	0.000169	CcSEcCtD
Posaconazole—Discomfort—Doxorubicin—pancreatic cancer	7.33e-05	0.000168	CcSEcCtD
Posaconazole—Anorexia—Epirubicin—pancreatic cancer	7.33e-05	0.000168	CcSEcCtD
Posaconazole—Dry mouth—Doxorubicin—pancreatic cancer	7.26e-05	0.000167	CcSEcCtD
Posaconazole—Vomiting—Docetaxel—pancreatic cancer	7.25e-05	0.000166	CcSEcCtD
Posaconazole—Rash—Docetaxel—pancreatic cancer	7.19e-05	0.000165	CcSEcCtD
Posaconazole—Hypotension—Epirubicin—pancreatic cancer	7.18e-05	0.000165	CcSEcCtD
Posaconazole—Dermatitis—Docetaxel—pancreatic cancer	7.18e-05	0.000165	CcSEcCtD
Posaconazole—Confusional state—Doxorubicin—pancreatic cancer	7.17e-05	0.000165	CcSEcCtD
Posaconazole—Headache—Docetaxel—pancreatic cancer	7.14e-05	0.000164	CcSEcCtD
Posaconazole—Oedema—Doxorubicin—pancreatic cancer	7.11e-05	0.000163	CcSEcCtD
Posaconazole—Infection—Doxorubicin—pancreatic cancer	7.07e-05	0.000162	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	7e-05	0.000161	CcSEcCtD
Posaconazole—Shock—Doxorubicin—pancreatic cancer	7e-05	0.000161	CcSEcCtD
Posaconazole—Nervous system disorder—Doxorubicin—pancreatic cancer	6.97e-05	0.00016	CcSEcCtD
Posaconazole—Thrombocytopenia—Doxorubicin—pancreatic cancer	6.96e-05	0.00016	CcSEcCtD
Posaconazole—Insomnia—Epirubicin—pancreatic cancer	6.95e-05	0.00016	CcSEcCtD
Posaconazole—Tachycardia—Doxorubicin—pancreatic cancer	6.94e-05	0.000159	CcSEcCtD
Posaconazole—Skin disorder—Doxorubicin—pancreatic cancer	6.91e-05	0.000159	CcSEcCtD
Posaconazole—Paraesthesia—Epirubicin—pancreatic cancer	6.9e-05	0.000158	CcSEcCtD
Posaconazole—Hyperhidrosis—Doxorubicin—pancreatic cancer	6.88e-05	0.000158	CcSEcCtD
Posaconazole—Dyspnoea—Epirubicin—pancreatic cancer	6.85e-05	0.000157	CcSEcCtD
Posaconazole—Somnolence—Epirubicin—pancreatic cancer	6.83e-05	0.000157	CcSEcCtD
Posaconazole—Anorexia—Doxorubicin—pancreatic cancer	6.78e-05	0.000156	CcSEcCtD
Posaconazole—Nausea—Docetaxel—pancreatic cancer	6.77e-05	0.000155	CcSEcCtD
Posaconazole—Dyspepsia—Epirubicin—pancreatic cancer	6.77e-05	0.000155	CcSEcCtD
Posaconazole—Decreased appetite—Epirubicin—pancreatic cancer	6.68e-05	0.000153	CcSEcCtD
Posaconazole—Hypotension—Doxorubicin—pancreatic cancer	6.65e-05	0.000153	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Epirubicin—pancreatic cancer	6.64e-05	0.000152	CcSEcCtD
Posaconazole—Fatigue—Epirubicin—pancreatic cancer	6.63e-05	0.000152	CcSEcCtD
Posaconazole—Pain—Epirubicin—pancreatic cancer	6.57e-05	0.000151	CcSEcCtD
Posaconazole—Constipation—Epirubicin—pancreatic cancer	6.57e-05	0.000151	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	6.48e-05	0.000149	CcSEcCtD
Posaconazole—Insomnia—Doxorubicin—pancreatic cancer	6.43e-05	0.000148	CcSEcCtD
Posaconazole—Paraesthesia—Doxorubicin—pancreatic cancer	6.39e-05	0.000147	CcSEcCtD
Posaconazole—Dyspnoea—Doxorubicin—pancreatic cancer	6.34e-05	0.000146	CcSEcCtD
Posaconazole—Feeling abnormal—Epirubicin—pancreatic cancer	6.33e-05	0.000145	CcSEcCtD
Posaconazole—Somnolence—Doxorubicin—pancreatic cancer	6.32e-05	0.000145	CcSEcCtD
Posaconazole—Gastrointestinal pain—Epirubicin—pancreatic cancer	6.29e-05	0.000144	CcSEcCtD
Posaconazole—Dyspepsia—Doxorubicin—pancreatic cancer	6.26e-05	0.000144	CcSEcCtD
Posaconazole—Decreased appetite—Doxorubicin—pancreatic cancer	6.18e-05	0.000142	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	6.14e-05	0.000141	CcSEcCtD
Posaconazole—Fatigue—Doxorubicin—pancreatic cancer	6.13e-05	0.000141	CcSEcCtD
Posaconazole—Urticaria—Epirubicin—pancreatic cancer	6.11e-05	0.00014	CcSEcCtD
Posaconazole—Pain—Doxorubicin—pancreatic cancer	6.08e-05	0.00014	CcSEcCtD
Posaconazole—Constipation—Doxorubicin—pancreatic cancer	6.08e-05	0.00014	CcSEcCtD
Posaconazole—Abdominal pain—Epirubicin—pancreatic cancer	6.08e-05	0.00014	CcSEcCtD
Posaconazole—Body temperature increased—Epirubicin—pancreatic cancer	6.08e-05	0.00014	CcSEcCtD
Posaconazole—Feeling abnormal—Doxorubicin—pancreatic cancer	5.86e-05	0.000135	CcSEcCtD
Posaconazole—Gastrointestinal pain—Doxorubicin—pancreatic cancer	5.82e-05	0.000134	CcSEcCtD
Posaconazole—Hypersensitivity—Epirubicin—pancreatic cancer	5.66e-05	0.00013	CcSEcCtD
Posaconazole—Urticaria—Doxorubicin—pancreatic cancer	5.65e-05	0.00013	CcSEcCtD
Posaconazole—Body temperature increased—Doxorubicin—pancreatic cancer	5.62e-05	0.000129	CcSEcCtD
Posaconazole—Abdominal pain—Doxorubicin—pancreatic cancer	5.62e-05	0.000129	CcSEcCtD
Posaconazole—Asthenia—Epirubicin—pancreatic cancer	5.52e-05	0.000127	CcSEcCtD
Posaconazole—Pruritus—Epirubicin—pancreatic cancer	5.44e-05	0.000125	CcSEcCtD
Posaconazole—Diarrhoea—Epirubicin—pancreatic cancer	5.26e-05	0.000121	CcSEcCtD
Posaconazole—Hypersensitivity—Doxorubicin—pancreatic cancer	5.24e-05	0.00012	CcSEcCtD
Posaconazole—Asthenia—Doxorubicin—pancreatic cancer	5.1e-05	0.000117	CcSEcCtD
Posaconazole—Dizziness—Epirubicin—pancreatic cancer	5.08e-05	0.000117	CcSEcCtD
Posaconazole—Pruritus—Doxorubicin—pancreatic cancer	5.03e-05	0.000116	CcSEcCtD
Posaconazole—Vomiting—Epirubicin—pancreatic cancer	4.89e-05	0.000112	CcSEcCtD
Posaconazole—Diarrhoea—Doxorubicin—pancreatic cancer	4.87e-05	0.000112	CcSEcCtD
Posaconazole—Rash—Epirubicin—pancreatic cancer	4.85e-05	0.000111	CcSEcCtD
Posaconazole—Dermatitis—Epirubicin—pancreatic cancer	4.84e-05	0.000111	CcSEcCtD
Posaconazole—Headache—Epirubicin—pancreatic cancer	4.82e-05	0.000111	CcSEcCtD
Posaconazole—Dizziness—Doxorubicin—pancreatic cancer	4.7e-05	0.000108	CcSEcCtD
Posaconazole—Nausea—Epirubicin—pancreatic cancer	4.57e-05	0.000105	CcSEcCtD
Posaconazole—Vomiting—Doxorubicin—pancreatic cancer	4.52e-05	0.000104	CcSEcCtD
Posaconazole—Rash—Doxorubicin—pancreatic cancer	4.48e-05	0.000103	CcSEcCtD
Posaconazole—Dermatitis—Doxorubicin—pancreatic cancer	4.48e-05	0.000103	CcSEcCtD
Posaconazole—Headache—Doxorubicin—pancreatic cancer	4.46e-05	0.000102	CcSEcCtD
Posaconazole—Nausea—Doxorubicin—pancreatic cancer	4.22e-05	9.7e-05	CcSEcCtD
